Aryl-derivatized, water-soluble functionalized carbon nanotubes for biomedical applications
Source abstract
Abstract
The functionalization of very-thin multi-walled carbon nanotubes (VT-MWNTs) with an aniline derivative, via the protocol of in situ generated aryl diazonium salts results, upon acidic deprotection of the terminal BOC group, on the formation of the water-soluble positively charged ammonium functionalized VT-MWNTs-NH3+ material. The new materials have been structurally and morphologically characterized by infra-red (ATR-IR) spectroscopy and transmission electron microscopy (TEM). The quantitative calculation of the grafted aryl units onto the skeleton of VT-MWNTs has been estimated by thermogravimetric analysis (TGA), while the quantitative Kaiser test showed the amine group loaded onto VT-MWNTs-NH3+ material. The aqueous solubility of this material has allowed the performance of some initial toxicological in vitro investigations. © 2008 Elsevier B.V. All rights reserved.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Carbon Nanotubes in Composites · Conducting polymers and applications · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (34)
Show source-provided references
1. Meyyappan · 2005
2. Katz · Chem. Phys. Chem. · 2004 · 5 · 108410.1002/cphc.200400193 ↗
3. Pagona · Curr. Med. Chem. · 2006 · 13 · 178910.2174/092986706777452524 ↗
4. Martin · Nat. Rev. Drug Discov. · 2003 · 2 · 2910.1038/nrd988 ↗
5. Bianco · Chem. Commun. · 2005 · 57110.1039/b410943k ↗
6. Kostarelos · J. Drug Deliv. Sci. Technol. · 2005 · 15 · 4110.1016/S1773-2247(05)50005-4 ↗
7. Kam · J. Am. Chem. Soc. · 2005 · 127 · 1249210.1021/ja053962k ↗
8. Bianco · Curr. Opin. Chem. Biol. · 2005 · 9 · 67410.1016/j.cbpa.2005.10.005 ↗
9. Tasis · Chem. Rev. · 2006 · 106 · 110510.1021/cr050569o ↗
10. Tasis · Chem. Eur. J. · 2003 · 9 · 400010.1002/chem.200304800 ↗
11. Hirsch · Angew. Chem. Int. · 2002 · 41 · 185310.1002/1521-3773(20020603)41:11<1853::AID-ANIE1853>3.0.CO;2-N ↗
12. Donaldson · Toxicol. Sci. · 2006 · 92 · 510.1093/toxsci/kfj130 ↗
13. Kam · J. Am. Chem. Soc. · 2005 · 127 · 621
14. Bahr · J. Am. Chem. Soc. · 2001 · 123 · 653610.1021/ja010462s ↗
15. Bahr · Chem. Mater. · 2001 · 13 · 382310.1021/cm0109903 ↗
16. Bahr · J. Mater. Chem. · 2002 · 12 · 195210.1039/b201013p ↗
17. Dyke · J. Am. Chem. Soc. · 2003 · 125 · 115610.1021/ja0289806 ↗
18. Dyke · Nano Lett. · 2003 · 3 · 121510.1021/nl034537x ↗
19. Dyke · Chem. Eur. J. · 2004 · 10 · 81210.1002/chem.200305534 ↗
20. Dyke · Synlett · 2004 · 155
21. Hudson · J. Am. Chem. Soc. · 2004 · 126 · 1115810.1021/ja0467061 ↗
22. Dyke · J. Phys. Chem. A · 2004 · 108 · 11152
23. Price · J. Am. Chem. Soc. · 2005 · 127 · 1486710.1021/ja053998c ↗
24. Stephenson · Chem. Mater. · 2006 · 18 · 37410.1021/cm052204q ↗
25. Pagona · Carbon · 2008 · 46 · 60410.1016/j.carbon.2008.01.007 ↗
26. Mosmann · J. Immunol. Methods · 1983 · 65 · 5510.1016/0022-1759(83)90303-4 ↗
27. Denizot · J. Immunol. Methods · 2007 · 89 · 27110.1016/0022-1759(86)90368-6 ↗
28. Vistica · Cancer Res. · 1991 · 51 · 2515
29. Hansen · J. Immunol. Methods · 1989 · 119 · 20310.1016/0022-1759(89)90397-9 ↗
30. Davoren · Toxicol. In vitro · 2007 · 21 · 43810.1016/j.tiv.2006.10.007 ↗
31. Sayes · Toxicol. Lett. · 2006 · 161 · 13510.1016/j.toxlet.2005.08.011 ↗
32. Cui · Toxicol. Lett. · 2005 · 155 · 7310.1016/j.toxlet.2004.08.015 ↗
33. Magrez · Nano Lett. · 2006 · 6 · 112110.1021/nl060162e ↗
34. Lacerda · Adv. Drug Deliv. Rev. · 2006 · 58 · 146010.1016/j.addr.2006.09.015 ↗